Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Bone Marrow Transplant. 2013 Feb 18;48(8):1056–1064. doi: 10.1038/bmt.2012.284

Table 3b.

Univariate probabilities of outcomes by whether received prior autologous transplant

Did not receive prior auto Received prior auto P-value

Outcome event N eval. Prob (95% CI)a N eval. Prob (95% CI)a
ANC > 0.5 × 109/L 69 42
  @ 28 days 78 (66-86) 90 (76-96) 0.0806
  @100 days 88 (78-94) 98 (84-100) 0.0433
Platelets > 20 × 109 /L 54 41
 @ 60 days 65 (50-76) 47 (28-64) 0.1309
 @100 days 69 (54-79) 50 (30-67) 0.1115
Acute GVHD, Grades 2-4 65 38
  @100 days 23 (14-34) 37 (22-52) 0.1466
  @ 180 days 25 (15-36) 37 (22-52) 0.202
Chronic GVHD 68 44
  @ 1 year 10 (5-19) 19 (9-32) 0.2359
  @ 3 years 12 (6-21) 19 (9-32) 0.3395
  @5 years 12 (6-21) 19 (9-32) 0.3395
Transplant-related mortality 73 42
  @ 100days 19 (11-29) 17 (7-29) 0.7332
  @ 1 year 25 (16-35) 24 (12-37) 0.8916
  @ 3 years 26 (17-37) 24 (12-37) 0.7572
  @ 5 years 26 (17-37) 24 (12-37) 0.7572
Relapse 73 42
  @ 1 year 27 (17-38) 57 (41-70) 0.0012
  @ 3 years 43 (31-55) 67 (50-79) 0.0131
  @ 5 years 46 (34-58) 70 (53-82) 0.0123
Disease-free survival 73 42
  @ 1 year 48 (36-59) 19 (9-32) 0.0006
  @ 3 years 30 (20-41) 10 (3-21) 0.0037
  @ 5 years 27 (17-38) 6 (1-17) 0.0018
Overall survival 97 46
  @ 1 year 59 (48-68) 50 (35-64) 0.3439
  @ 3 years 36 (26-46) 16 (7-28) 0.0086
  @ 5 years 29 (20-39) 7 (1-18) 0.0005